Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A new method for preparing the key intermediate of uliplast acetate

An ethylenedioxy, norpregnant technology, applied in steroids, organic chemistry and other directions, can solve the problems of unfavorable product quality, many by-products, difficult purification of final products, etc., and achieves high yield and selectivity , the effect of more controllable response

Active Publication Date: 2017-02-22
CHANGZHOU YABANG PHARMA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] This route needs to use metal lithium when preparing 17α-hydroxyl-19-norpregna-4,9-diene-3,20-dione (IV), and metal lithium is a very high chemical reaction Alkali metal will burn violently when it meets water or acid, releasing hydrogen and heat, which is extremely unsuitable for large-scale industrial production
Secondly, this route uses cuprous chloride catalyst in the 1,4-conjugated addition reaction of last step, and the yield of reaction is only 76%, and by product is more, causes difficulty to the purification of final product, is unfavorable for product quality improvement

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A new method for preparing the key intermediate of uliplast acetate
  • A new method for preparing the key intermediate of uliplast acetate
  • A new method for preparing the key intermediate of uliplast acetate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Example 1: 3,3-ethylenedioxy-17β-cyano-17α-chloromethyl (dimethyl) siloxyestradiol-5 (10), the preparation of 9 (11) diene (III )

[0022] Add 3,3-ethylenedioxy-17β-cyanoestro-5(10), 9(11)dien-17α-alcohol (II) 170.5g and 5L tetrahydrofuran into the reaction flask in sequence, and start stirring , the temperature was lowered to 5°C, 12.2 g of 4-dimethylaminopyridine and 96.5 mL of triethylamine were added, 79.0 mL of chloromethyldimethylsilyl chloride was added dropwise, and the reaction was stirred at room temperature for 12 hours. Concentrate to dryness under reduced pressure at room temperature, add 1500 mL of dichloromethane, and pour the reaction solution into 800 mL of saturated aqueous sodium bicarbonate solution while stirring. The liquid was separated, and the organic phase was concentrated to dryness under reduced pressure, 500 mL of isopropyl ether was added, filtered, and the filter cake was air-dried to obtain 219.5 g of off-white solid, with a yield of 98....

Embodiment 2

[0023] Example 2: Preparation of 17α-hydroxy-19-norpregna-4,9-diene-3,20-dione (IV)

[0024]Add 219.5 g of 3,3-ethylenedioxy-17β-cyano-17α-chloromethyl (dimethyl) siloxyestradiol-5(10), 9(11) diene (III) to In a mixed solvent of 500mL toluene and 500mL tetrahydrofuran, after stirring at room temperature for 15min, 7.0g of cuprous bromide was added and added dropwise at room temperature. After the dropwise addition, continue to stir for 23 hours, distill off the solvent under reduced pressure, slowly add 300mL of 5% dilute hydrochloric acid, continue to stir at room temperature for 30min, and extract twice with dichloromethane (500mL×2). Wash once with saturated saline and water, dry over anhydrous magnesium sulfate, and filter. The filtrate is concentrated to dryness to obtain 142.2 g of the product, with a yield of 92.3%.

Embodiment 3

[0025] Example 3: Preparation of 3,3,20,20-bis(ethylenedioxy)-17α-hydroxyl-5α, 10α-epoxy-19-norpregna-9(11)-ene (V)

[0026] Mix 17α-hydroxy-19-norpregna-4,9-diene-3,20-dione 138.7g (IV), 122.9mL ethylene glycol and 1500mL dichloromethane, start stirring, add dropwise at room temperature A solution of triethyl orthoformate (220.4 mL) in 200 mL of dichloromethane. After the dropwise addition, 5.1 g of p-toluenesulfonic acid was added, and after stirring at room temperature for 18 hours, 700 mL of saturated sodium bicarbonate solution was slowly added dropwise. After dropping, the liquid was separated, and the organic phase was washed with saturated brine and 700 mL of water successively. After drying the organic phase over anhydrous magnesium sulfate, filter, add 71.2 g of hexafluoroacetone to the obtained dichloromethane filtrate, start stirring and cool to 4 ° C, dropwise add 30% hydrogen peroxide (125 mL) and disodium hydrogen phosphate (25 g) to mix After the solution was...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel preparation method of ulipristal acetate key intermediate 3,3,20,20-double (ethylenedioxy group)-5 alpha, 17 alpha- dihydroxyl-11 bata-[4-(N,N- dimethyl amidogen)- phenyl]-19-norprogesterone-9(11)-alkene, namely 3,3- ethylenedioxy group-17 beta-cyangroup female steroid-5(10), 9(11) diene-17 alpha-alcohol is used as a raw material, through the protection of hydroxyl, the addition of Grignard reagent and cyangroup, and the protection of ketal, and the target compound is obtained finally through 1,4 addition of alpha, beta unsaturation epoxide under the catalysis of a system of cuprous halides and dimethyl sulfide. The raw materials used in the method are safe and reliable, reaction is easy to control, reaction yield and stereoselectivity are high, and the method is applicable for industrial production.

Description

technical field [0001] The present invention relates to the key intermediate 3,3,20,20-bis(ethylenedioxy)-5α,17α-dihydroxy-11β-[4-(N,N-dimethylamino) of uliplast acetate Process for the preparation of -phenyl]-19-norpregna-9(11)-ene. Background technique [0002] Uliplast acetate is a progesterone receptor modulator developed by HRA Pharmaceuticals and approved by the European Commission in May 2009 for unprotected sexual intercourse or oral use within 120 hours of contraceptive failure. contraceptive pills. The chemical name of uliplast acetate is 17α-(acetoxy)-11β-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20- Diketones, the structure of which is shown below: [0003] [0004] 3,3,20,20-Bis(ethylenedioxy)-5α,17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl]-19-norpregna -9(11)-ene is a key intermediate for the synthesis and preparation of uliplast acetate, and its structure is shown in the following formula (I): [0005] [0006] 3,3,20,20-Bis(ethylenedio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07J21/00
Inventor 陈再新夏正君张明光王明林林送吉小龙马堰启臧路杰袁满龙
Owner CHANGZHOU YABANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com